2026 ICD-10-CM Diagnosis Code E88.42MERRF syndrome

ICD-10-CM CodesE00–E89E70-E88E88

ICD-10-CM E88.42
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

E88.42 is a billable ICD-10-CM diagnosis code for MERRF syndrome. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as myoclonic epilepsy with ragged red fibers. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.

Code Identity

ICD-10-CM Code
E88.42
Billable Status
Yes — Valid for Submission
Code Describes
MERRF syndrome
Short Description
MERRF syndrome
Same as the full description in the CMS dataset.
Parent Code
Mitochondrial metabolism disorders

Code Classification

ChapterE00–E89Endocrine, nutritional and metabolic diseases
SectionE70-E88Metabolic disorders
CategoryE88Other and unspecified metabolic disorders
This CodeE88.42MERRF syndrome

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Myoclonic epilepsy with ragged red fibers

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Myoclonic epilepsy associated with ragged-red fibers

Code Also

  • progressive myoclonic epilepsy G40.3

Index to Diseases and InjuriesGuidance

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Disorder(of)
      • metabolism NOS
        • mitochondrial
          • MERRF syndrome (myoclonic epilepsy associated with ragged-red fibers)
    • MERRF syndrome(myoclonic epilepsy associated with ragged-red fiber)
    • Syndrome
      • MERRF (myoclonic epilepsy associated with ragged-red fibers)

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR END016
Other specified and unspecified nutritional and metabolic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • MERRF Syndrome

    a mitochondrial encephalomyopathy characterized clinically by a mixed seizure disorder, myoclonus, progressive ataxia, spasticity, and a mild myopathy. dysarthria, optic atrophy, growth retardation, deafness, and dementia may also occur. this condition tends to present in childhood and to be transmitted via maternal lineage. muscle biopsies reveal ragged-red fibers and respiratory chain enzymatic defects. (from adams et al., principles of neurology, 6th ed, p986)

Patient EducationClinical

Metabolic Disorders

Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system break the food parts down into sugars and acids, your body's fuel.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert E88.42 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
277.87 Dis mitochondrial metab
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About E88.42Overview

Is E88.42 (Mitochondrial metabolism disorders) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report MERRF syndrome on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of E88.42?

Under the General Equivalence Mappings, MERRF syndrome converts to ICD-9-CM 277.87 (dis mitochondrial metab). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.